Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 12 studies | 27% ± 11% | |
| macrophage | 9 studies | 24% ± 7% | |
| classical monocyte | 9 studies | 27% ± 14% | |
| microglial cell | 9 studies | 30% ± 12% | |
| conventional dendritic cell | 8 studies | 26% ± 12% | |
| dendritic cell | 4 studies | 18% ± 2% | |
| mononuclear phagocyte | 3 studies | 33% ± 18% | |
| myeloid cell | 3 studies | 21% ± 3% | |
| monocyte | 3 studies | 27% ± 6% |
Insufficient scRNA-seq data for expression of P2RY13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 80% | 218.16 | 2118 / 2642 | 98% | 19.01 | 689 / 705 |
| lung | 98% | 418.25 | 565 / 578 | 77% | 6.52 | 889 / 1155 |
| breast | 64% | 74.02 | 295 / 459 | 77% | 5.83 | 863 / 1118 |
| kidney | 44% | 46.65 | 39 / 89 | 82% | 8.63 | 736 / 901 |
| intestine | 75% | 172.32 | 724 / 966 | 50% | 2.82 | 263 / 527 |
| adrenal gland | 82% | 120.83 | 212 / 258 | 40% | 1.62 | 93 / 230 |
| prostate | 66% | 73.60 | 161 / 245 | 52% | 2.36 | 262 / 502 |
| thymus | 39% | 40.32 | 255 / 653 | 77% | 5.06 | 466 / 605 |
| stomach | 47% | 51.30 | 168 / 359 | 62% | 4.49 | 177 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 25.66 | 29 / 29 |
| spleen | 100% | 4688.36 | 241 / 241 | 0% | 0 | 0 / 0 |
| bladder | 57% | 52.29 | 12 / 21 | 41% | 2.66 | 209 / 504 |
| esophagus | 53% | 54.44 | 765 / 1445 | 42% | 2.02 | 77 / 183 |
| pancreas | 25% | 21.02 | 81 / 328 | 63% | 4.02 | 112 / 178 |
| liver | 56% | 88.17 | 127 / 226 | 31% | 1.46 | 124 / 406 |
| adipose | 84% | 179.80 | 1009 / 1204 | 0% | 0 | 0 / 0 |
| skin | 32% | 26.95 | 577 / 1809 | 51% | 4.08 | 239 / 472 |
| peripheral blood | 81% | 10754.04 | 756 / 929 | 0% | 0 | 0 / 0 |
| uterus | 36% | 29.96 | 61 / 170 | 39% | 2.10 | 178 / 459 |
| ovary | 18% | 14.94 | 33 / 180 | 54% | 3.05 | 231 / 430 |
| tonsil | 0% | 0 | 0 / 0 | 67% | 6.59 | 30 / 45 |
| blood vessel | 46% | 65.16 | 609 / 1335 | 0% | 0 | 0 / 0 |
| heart | 35% | 30.17 | 299 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 24% | 0.96 | 19 / 80 |
| muscle | 4% | 2.42 | 31 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0035589 | Biological process | G protein-coupled purinergic nucleotide receptor signaling pathway |
| GO_0071407 | Biological process | cellular response to organic cyclic compound |
| GO_0008150 | Biological process | biological_process |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| GO_0045028 | Molecular function | G protein-coupled purinergic nucleotide receptor activity |
| Gene name | P2RY13 |
| Protein name | P2Y purinoceptor 13 (P2Y13) (G-protein coupled receptor 86) (G-protein coupled receptor 94) Purinergic receptor P2Y G-protein coupled 13 (Purinergic receptor P2Y, G-protein coupled, 13, isoform CRA_b) |
| Synonyms | GPR94 hCG_1786970 FKSG77 GPR86 |
| Description | FUNCTION: Receptor for ADP. Coupled to G(i)-proteins. May play a role in hematopoiesis and the immune system. . |
| Accessions | ENST00000325602.6 [Q9BPV8-1] Q9BPV8 G4XH60 |
